These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2008-007058-36 A Phase III Study of Microsomal Triglyceride Transfer Protein (MTP) Inhibitor AEGR-733 in Patients with Homozygous Familial Hypercholesterolemia on Current Lipid-lowering Therapy 2011-10-13 due-trials
Reported results 2010-023742-79 A Phase III, Long Term, Open Label, Follow on Study of Microsomal Triglyceride Transfer Protein (MTP) Inhibitor ‘lomitapide’ (AEGR-733) in Patients with Homozygous Familial Hypercholesterolemia 2015-02-10 due-trials
Exempt, with results 2012-004220-37 A randomised, double-blind, placebo-controlled, single ascending and multiple ascending dose study of the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of lomitapide in Japanes... 2013-07-22 not-yet-due
Exempt, with results 2013-002692-17 A Phase 1, Open-label, Crossover Study to Determine the intra-subject variability of the Pharmacokinetics of Single Oral Capsule Doses of 20 mg Lomitapide in Healthy Subjects 2013-08-23 not-yet-due
Other 2014-003806-33 A Phase 3, Single-arm, Open-label, International, Multi-center Study to Evaluate the Efficacy and Safety of Lomitapide in Pediatric Patients with Homozygous Familial Hypercholesterolemia on Stable Lip... not-yet-due